BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24626656)

  • 41. The different faces of cutaneous lupus erythematosus.
    Renner R; Sticherling M
    G Ital Dermatol Venereol; 2009 Apr; 144(2):135-47. PubMed ID: 19357621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
    Zhou W; Wu H; Zhao M; Lu Q
    Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Subacute cutaneous lupus erythematosus based on a study of 15 cases].
    Marschalkó M; Dobozy E; Daróczy J; Gyimesi E; Horváth A
    Orv Hetil; 1989 Dec; 130(49):2623-8. PubMed ID: 2689950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of systemic lupus in patients with cutaneous lupus using the 2012 Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for systemic lupus erythematosus.
    Black SM; Walocko F; Li X; Chong BF
    J Am Acad Dermatol; 2021 Jul; 85(1):200-202. PubMed ID: 33421477
    [No Abstract]   [Full Text] [Related]  

  • 45. Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
    Foulke G; Helm LA; Clebak KT; Helm M
    FP Essent; 2023 Mar; 526():25-36. PubMed ID: 36913660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical and Rare Forms of Cutaneous Lupus Erythematosus: The Importance of the Diagnosis for the Best Management of Patients.
    Herzum A; Gasparini G; Cozzani E; Burlando M; Parodi A
    Dermatology; 2022; 238(2):195-204. PubMed ID: 34082424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous lupus erythematosus in skin of color.
    Nozile W; Adgerson CN; Cohen GF
    J Drugs Dermatol; 2015 Apr; 14(4):343-9. PubMed ID: 25844606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus].
    Sticherling M
    Z Rheumatol; 2013 Jun; 72(5):429-35. PubMed ID: 23743985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous lupus erythematosus in India: immunofluorescence profile.
    George R; Mathai R; Kurian S
    Int J Dermatol; 1992 Apr; 31(4):265-9. PubMed ID: 1634292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Even the most severe of lupus skin lesions can heal.
    Singh A; Dhir V; Sekar A; Nada R; Jain S
    Rheumatology (Oxford); 2024 Feb; 63(2):e69-e70. PubMed ID: 37540181
    [No Abstract]   [Full Text] [Related]  

  • 52. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
    Tiao J; Feng R; Carr K; Okawa J; Werth VP
    J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current diagnosis of cutaneous lupus erythematosus].
    Haust M; Bonsmann G; Kuhn A
    Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1594-8. PubMed ID: 16823708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lupus erythematosus: systemic and cutaneous manifestations.
    Rothfield N; Sontheimer RD; Bernstein M
    Clin Dermatol; 2006; 24(5):348-62. PubMed ID: 16966017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cutaneous lupus erythematosus: a personal approach to management.
    Callen JP
    Australas J Dermatol; 2006 Feb; 47(1):13-27. PubMed ID: 16405478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.
    Tzellos TG; Kouvelas D
    Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skin CD4
    Zhao Z; Zhu H; Li Q; Liao W; Chen K; Yang M; Long D; He Z; Zhao M; Wu H; Lu Q
    J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.
    Chen KL; Krain RL; Werth VP
    F1000Res; 2019; 8():. PubMed ID: 30984372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypertrophic lupus erythematosus complicating long-standing systemic lupus erythematosus.
    Bernardi M; Bahrami S; Callen JP
    Lupus; 2011 Apr; 20(5):549-50. PubMed ID: 21300682
    [No Abstract]   [Full Text] [Related]  

  • 60. Worsening skin damage in patients with cutaneous lupus erythematosus may predict development of systemic lupus erythematosus.
    Walocko F; Black S; Anderson S; Li X; Adams-Huet B; Chong BF
    J Am Acad Dermatol; 2021 Feb; 84(2):538-540. PubMed ID: 32407740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.